Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceuticals Company achieves pretax income of JD0.56 million in Q1 2013

2013-05-01

According to Jerusalem Pharmaceuticals Company ( JPH)’s  data for the first three months of the year, net profit before tax reached 561,828 JOD, compared with a net loss of (219,585) JOD from the first three months of 2012. Total assets of the company reached 35,760,807 JOD as of March 31st, 2013, compared to total assets of 34,652,743 JOD as of December 31st, 2012, a net increase of 3.2%. Total liabilities of the company reached 11,787,956 JOD as of March 31st, 2013, compared to total liabilities of 10,751,846 JOD as of December 31st, 2012, a net increase of 9.6%. Net ownership equity of the company reached 23,972,851 JOD (including 640,866 JOD in Non-controlling interest) as of March 31st, 2013, compared with a net ownership equity of 23,900,897 JOD (including 674,614 JOD in Non-controlling interest) as of December 31st, 2012, a net increase of 0.3% in the first three months.

 


 

2017-07-20
High liquidity level raises the market's trading volume this week

2017-07-18
PICO approves raising the paid-capital to $6 million

2017-07-18
TIC approves raising the paid-capital to $10.00 million

2017-07-13
Active Trading with the increase of semi-annual financial data anticipation

2017-07-12
LADAEN restructures itself and establishes a new company

2017-07-06
Al-Quds Index breaks through new psychological level and gains 2.99% in this week

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013